These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 82699)

  • 1. Rapid diagnosis using surface analysis by bacterial adherence.
    Huang AS; Okorie T
    Lancet; 1978 Nov; 2(8100):1146. PubMed ID: 82699
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface analysis by bacterial adherence to virus-infected cells.
    Huang AS; Okorie TG
    J Infect Dis; 1979 Aug; 140(2):147-51. PubMed ID: 225389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane.
    Wagner RR; Heine JW; Goldstein G; Schnaitman CA
    J Virol; 1971 Feb; 7(2):274-7. PubMed ID: 4106782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of the cells which synthesize the immunoglobulins.
    Gowans JL
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):201-11. PubMed ID: 4142552
    [No Abstract]   [Full Text] [Related]  

  • 5. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

  • 6. Independent movement of surface immunoglobulin from Fc receptors on lymphocyte membranes.
    Ramasamy R; Lawson Y
    Immunology; 1975 Feb; 28(2):301-4. PubMed ID: 1123249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of surface antigen by specific bacterial adherence and scanning electron microscopy (SABA/SEM) in cells infected by vesiculovirus ts mutants.
    Pringle CR; Parry JE
    J Gen Virol; 1982 Mar; 59(Pt 1):207-11. PubMed ID: 6279772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopic study of development of vesicular stomatitis virus using ferritin-labelled antibodies.
    Coward JE; Harter DH; Hsu KC; Morgan C
    J Gen Virol; 1971 Oct; 13(1):27-34. PubMed ID: 4108672
    [No Abstract]   [Full Text] [Related]  

  • 9. Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.
    Verbrugh HA; Hoidal JR; Nguyen BY; Verhoef J; Quie PG; Peterson PK
    J Clin Invest; 1982 Jan; 69(1):63-74. PubMed ID: 7054243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
    Závadová Z; Závada J
    Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-isolation of vesicles using antigenic sites either located on the cytoplasmic or the exoplasmic domain of an implanted viral protein. A quantitative analysis.
    Gruenberg J; Howell KE
    Eur J Cell Biol; 1985 Sep; 38(2):312-21. PubMed ID: 2995034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute leukemia: the use of surface markers in classification.
    Humphrey GB; Lankford J
    Semin Oncol; 1976 Sep; 3(3):243-51. PubMed ID: 185724
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for a host cell component in vesicular stomatitis virus.
    Cartwright B; Pearce CA
    J Gen Virol; 1968 Mar; 2(2):207-14. PubMed ID: 4297603
    [No Abstract]   [Full Text] [Related]  

  • 15. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components.
    Brown F; Cartwright B; Almeida JD
    J Immunol; 1966 Mar; 96(3):537-45. PubMed ID: 4286685
    [No Abstract]   [Full Text] [Related]  

  • 17. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface T-and B-cell markers on murine lymphomas and plasmacytomas.
    Ramasamy R; Munro AJ
    Immunology; 1974 Mar; 26(3):563-70. PubMed ID: 4605189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of virus proteins in BHK 21 cells infected with vesicular stomatitis virus (Indiana C).
    Cartwright B
    J Gen Virol; 1973 Nov; 21(2):407-11. PubMed ID: 4357752
    [No Abstract]   [Full Text] [Related]  

  • 20. Vesicular stomatitis virus phenotypically mixed with retroviruses: an efficient detection method.
    Závada J; Russ G; Závadová Z; Sabó A
    Acta Virol; 1983 Mar; 27(2):110-8. PubMed ID: 6135329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.